Join to view full profile
14351 Myford RdSuite BTustin, CA 92780
Phone+1 714-550-9990
Fax+1 714-550-1226
Dr. Neutel is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of California (Irvine)Residency, Internal Medicine, 1991 - 1993
University of the WitwatersrandClass of 1983
Certifications & Licensure
CA State Medical License 1992 - 2028
Clinical Trials
- Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL): A Trial To Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly In Patients With Type 2 Diabetes Mellitus Start of enrollment: 2010 Jun 18
- Efficacy and Safety of Human Neuregulin-1 to Treat Stable Chronic Heart Failure
- Evaluation of Cross-Linked Polyelectrolyte (CLP) With Placebo in Heart Failure Subjects
Publications & Presentations
PubMed
- Effects of renal impairment on the pharmacokinetics, safety, and tolerability of pudexacianinium (ASP5354) after IV administration: a mechanistic exploration.Tomoki Kojima, Masako Saito, Toshihiro Matsuda, Neal Simmons, Masanori Nagata
European Journal of Clinical Pharmacology. 2026-04-25 - 19 citationsAdd-On Treatment With Zilebesiran for Inadequately Controlled Hypertension: The KARDIA-2 Randomized Clinical Trial.Akshay S Desai, Adam D Karns, Jolita Badariene, Ahmad Aswad, Joel M Neutel
JAMA. 2025-07-01 - 8 citationsRandomized Study Comparing a Novel Intranasal Formulation of Bumetanide With Oral and Intravenous Formulations.Andrew P Ambrosy, Daniel Bensimhon, Galina Bernstein, Brian Kolski, Joel Neutel
Circulation. 2025-03-11
Journal Articles
- Very High-Protein and Low-Carbohydrate Enteral Nutrition Formula and Plasma Glucose Control in Adults with Type 2 Diabetes Mellitus: A Randomized Crossover TrialJoel Neutel, MD, Nature
Press Mentions
BioCorRx Completes Enrollment in Trial of Naltrexone Implant for Treating Opioid Use DisorderOctober 13th, 2022- OC Firm Fighting Addiction Seeks Volunteers for Clinical TrialJuly 7th, 2022
- BioCorRx Begins Recruitment for Clinical Trial of BICX104, an Implantable Naltrexone Pellet for the Treatment of Opioid Use DisorderApril 27th, 2022
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
